Quality of life and quality-adjusted survival (Q-TWiST) in patients receiving dose-intensive or standard dose chemotherapy for high-risk primary breast cancer

Quality of life (QL) is an important consideration when comparing adjuvant therapies for early breast cancer, especially if they differ substantially in toxicity. We evaluated QL and Q-TWiST among patients randomised to adjuvant dose-intensive epirubicin and cyclophosphamide administered with filgra...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: Bernhard, J, Zahrieh, D, Zhang, J J, Martinelli, G, Basser, R, Hürny, C, Forbes, J F, Aebi, S, Yeo, W, Thürlimann, B, Green, M D, Colleoni, M, Gelber, R D, Castiglione-Gertsch, M, Price, K N, Goldhirsch, A, Coates, A S
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Nature Publishing Group 2008
Pynciau:
Clinical Study
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC2359705/
https://ncbi.nlm.nih.gov/pubmed/18043579
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6604092
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg